Bellevue Asset Management’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-40
Closed -$4.09K 421
2025
Q4
$4.09K Hold
40
﹤0.01% 364
2025
Q3
$2.5K Buy
+40
New +$2.18K ﹤0.01% 415

Other funds holding GH

Bellevue Asset Management's GH Position: Q1 2026 in Review

Bellevue Asset Management sold out of Guardant Health (GH) in Q1 2026, closing a stake of 40 shares — an estimated $4.09K sold.

Bellevue Asset Management first reported a position in GH in Q3 2025 and held it in 2 quarters. The position peaked at $4.09K in Q4 2025. 481 funds tracked by Wall St. Rank hold GH as of Q1 2026.

  • Bellevue Asset Management reported no remaining Guardant Health position as of Q1 2026 after selling out during the quarter.
  • Bellevue Asset Management sold 40 Guardant Health shares in Q1 2026, an estimated $4.09K.
  • Bellevue Asset Management first reported a position in Guardant Health in Q3 2025 and held it in 2 quarters.
  • Bellevue Asset Management's Guardant Health position peaked at $4.09K in Q4 2025.
  • 481 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.

Based on Bellevue Asset Management's 13F filing for Q1 2026, filed 24 Apr 2026.